Copyright Reports & Markets. All rights reserved.

Global Tuberculosis Vaccine Treatment Market Insights and Forecast to 2027

Request for Sample of this report
Buy now

1 Study Coverage

  • 1.1 Tuberculosis Vaccine Treatment Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Type
    • 1.4.2 Immune Vaccine
    • 1.4.3 Therapy Vaccine
  • 1.3 Market by Application
    • 1.3.1 Global Tuberculosis Vaccine Treatment Market Size Growth Rate by Application
    • 1.3.2 Self-Procurement
    • 1.3.3 UNICEF
    • 1.3.4 Other
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Tuberculosis Vaccine Treatment Sales Estimates and Forecasts 2016-2027
  • 2.2 Global Tuberculosis Vaccine Treatment Revenue Estimates and Forecasts 2016-2027
  • 2.3 Global Tuberculosis Vaccine Treatment Revenue by Region: 2016 VS 2021 VS 2027
  • 2.4 Global Top Tuberculosis Vaccine Treatment Regions by Sales
    • 2.4.1 Global Top Tuberculosis Vaccine Treatment Regions by Sales (2016-2021)
    • 2.4.2 Global Top Tuberculosis Vaccine Treatment Regions by Sales (2022-2027)
  • 2.5 Global Top Tuberculosis Vaccine Treatment Regions by Revenue
    • 2.5.1 Global Top Tuberculosis Vaccine Treatment Regions by Revenue (2016-2021)
    • 2.5.2 Global Top Tuberculosis Vaccine Treatment Regions by Revenue (2022-2027)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Tuberculosis Vaccine Treatment Sales by Manufacturers
    • 3.1.1 Global Top Tuberculosis Vaccine Treatment Manufacturers by Sales (2016-2021)
    • 3.1.2 Global Top Tuberculosis Vaccine Treatment Manufacturers Market Share by Sales (2016-2021)
    • 3.1.3 Global Top 10 and Top 5 Companies by Tuberculosis Vaccine Treatment Sales in 2020
  • 3.2 Global Tuberculosis Vaccine Treatment Revenue by Manufacturers
    • 3.2.1 Global Top Tuberculosis Vaccine Treatment Manufacturers by Revenue (2016-2021)
    • 3.2.2 Global Top Tuberculosis Vaccine Treatment Manufacturers Market Share by Revenue (2016-2021)
    • 3.2.3 Global Top 10 and Top 5 Companies by Tuberculosis Vaccine Treatment Revenue in 2020
  • 3.3 Global Tuberculosis Vaccine Treatment Sales Price by Manufacturers
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Tuberculosis Vaccine Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Tuberculosis Vaccine Treatment Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Tuberculosis Vaccine Treatment Sales by Type
    • 4.1.1 Global Tuberculosis Vaccine Treatment Historical Sales by Type (2016-2021)
    • 4.1.2 Global Tuberculosis Vaccine Treatment Forecasted Sales by Type (2022-2027)
    • 4.1.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Type (2016-2027)
  • 4.2 Global Tuberculosis Vaccine Treatment Revenue by Type
    • 4.2.1 Global Tuberculosis Vaccine Treatment Historical Revenue by Type (2016-2021)
    • 4.2.2 Global Tuberculosis Vaccine Treatment Forecasted Revenue by Type (2022-2027)
    • 4.2.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Type (2016-2027)
  • 4.3 Global Tuberculosis Vaccine Treatment Price by Type
    • 4.3.1 Global Tuberculosis Vaccine Treatment Price by Type (2016-2021)
    • 4.3.2 Global Tuberculosis Vaccine Treatment Price Forecast by Type (2022-2027)

5 Market Size by Application

  • 5.1 Global Tuberculosis Vaccine Treatment Sales by Application
    • 5.1.1 Global Tuberculosis Vaccine Treatment Historical Sales by Application (2016-2021)
    • 5.1.2 Global Tuberculosis Vaccine Treatment Forecasted Sales by Application (2022-2027)
    • 5.1.3 Global Tuberculosis Vaccine Treatment Sales Market Share by Application (2016-2027)
  • 5.2 Global Tuberculosis Vaccine Treatment Revenue by Application
    • 5.2.1 Global Tuberculosis Vaccine Treatment Historical Revenue by Application (2016-2021)
    • 5.2.2 Global Tuberculosis Vaccine Treatment Forecasted Revenue by Application (2022-2027)
    • 5.2.3 Global Tuberculosis Vaccine Treatment Revenue Market Share by Application (2016-2027)
  • 5.3 Global Tuberculosis Vaccine Treatment Price by Application
    • 5.3.1 Global Tuberculosis Vaccine Treatment Price by Application (2016-2021)
    • 5.3.2 Global Tuberculosis Vaccine Treatment Price Forecast by Application (2022-2027)

6 North America

  • 6.1 North America Tuberculosis Vaccine Treatment Market Size by Type
    • 6.1.1 North America Tuberculosis Vaccine Treatment Sales by Type (2016-2027)
    • 6.1.2 North America Tuberculosis Vaccine Treatment Revenue by Type (2016-2027)
  • 6.2 North America Tuberculosis Vaccine Treatment Market Size by Application
    • 6.2.1 North America Tuberculosis Vaccine Treatment Sales by Application (2016-2027)
    • 6.2.2 North America Tuberculosis Vaccine Treatment Revenue by Application (2016-2027)
  • 6.3 North America Tuberculosis Vaccine Treatment Market Size by Country
    • 6.3.1 North America Tuberculosis Vaccine Treatment Sales by Country (2016-2027)
    • 6.3.2 North America Tuberculosis Vaccine Treatment Revenue by Country (2016-2027)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Tuberculosis Vaccine Treatment Market Size by Type
    • 7.1.1 Europe Tuberculosis Vaccine Treatment Sales by Type (2017-2027)
    • 7.1.2 Europe Tuberculosis Vaccine Treatment Revenue by Type (2017-2027)
  • 7.2 Europe Tuberculosis Vaccine Treatment Market Size by Application
    • 7.2.1 Europe Tuberculosis Vaccine Treatment Sales by Application (2017-2027)
    • 7.2.2 Europe Tuberculosis Vaccine Treatment Revenue by Application (2017-2027)
  • 7.3 Europe Tuberculosis Vaccine Treatment Market Size by Country
    • 7.3.1 Europe Tuberculosis Vaccine Treatment Sales by Country (2017-2027)
    • 7.3.2 Europe Tuberculosis Vaccine Treatment Revenue by Country (2017-2027)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Tuberculosis Vaccine Treatment Market Size by Type
    • 8.1.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Type (2018-2027)
    • 8.1.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Type (2018-2027)
  • 8.2 Asia Pacific Tuberculosis Vaccine Treatment Market Size by Application
    • 8.2.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Application (2018-2027)
    • 8.2.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Application (2018-2027)
  • 8.3 Asia Pacific Tuberculosis Vaccine Treatment Market Size by Region
    • 8.3.1 Asia Pacific Tuberculosis Vaccine Treatment Sales by Region (2018-2027)
    • 8.3.2 Asia Pacific Tuberculosis Vaccine Treatment Revenue by Region (2018-2027)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Tuberculosis Vaccine Treatment Market Size by Type
    • 9.1.1 Latin America Tuberculosis Vaccine Treatment Sales by Type (2019-2027)
    • 9.1.2 Latin America Tuberculosis Vaccine Treatment Revenue by Type (2019-2027)
  • 9.2 Latin America Tuberculosis Vaccine Treatment Market Size by Application
    • 9.2.1 Latin America Tuberculosis Vaccine Treatment Sales by Application (2019-2027)
    • 9.2.2 Latin America Tuberculosis Vaccine Treatment Revenue by Application (2019-2027)
  • 9.3 Latin America Tuberculosis Vaccine Treatment Market Size by Country
    • 9.3.1 Latin America Tuberculosis Vaccine Treatment Sales by Country (2019-2027)
    • 9.3.2 Latin America Tuberculosis Vaccine Treatment Revenue by Country (2019-2027)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

6 Middle East and Africa

  • 6.1 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Type
    • 6.1.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Type (2016-2027)
    • 6.1.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Type (2016-2027)
  • 6.2 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Application
    • 6.2.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Application (2016-2027)
    • 6.2.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Application (2016-2027)
  • 6.3 Middle East and Africa Tuberculosis Vaccine Treatment Market Size by Country
    • 6.3.1 Middle East and Africa Tuberculosis Vaccine Treatment Sales by Country (2016-2027)
    • 6.3.2 Middle East and Africa Tuberculosis Vaccine Treatment Revenue by Country (2016-2027)
    • 6.3.3 Turkey
    • 6.3.4 Saudi Arabia
    • 6.3.5 UAE

11 Company Profiles

  • 11.1 Merck
    • 11.1.1 Merck Corporation Information
    • 11.1.2 Merck Overview
    • 11.1.3 Merck Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Merck Tuberculosis Vaccine Treatment Product Description
    • 11.1.5 Merck Related Developments
  • 11.2 Japan BCG Lab
    • 11.2.1 Japan BCG Lab Corporation Information
    • 11.2.2 Japan BCG Lab Overview
    • 11.2.3 Japan BCG Lab Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.2.4 Japan BCG Lab Tuberculosis Vaccine Treatment Product Description
    • 11.2.5 Japan BCG Lab Related Developments
  • 11.3 Serum Institute of India
    • 11.3.1 Serum Institute of India Corporation Information
    • 11.3.2 Serum Institute of India Overview
    • 11.3.3 Serum Institute of India Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.3.4 Serum Institute of India Tuberculosis Vaccine Treatment Product Description
    • 11.3.5 Serum Institute of India Related Developments
  • 11.4 AJ Vaccines
    • 11.4.1 AJ Vaccines Corporation Information
    • 11.4.2 AJ Vaccines Overview
    • 11.4.3 AJ Vaccines Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.4.4 AJ Vaccines Tuberculosis Vaccine Treatment Product Description
    • 11.4.5 AJ Vaccines Related Developments
  • 11.5 BioFarma
    • 11.5.1 BioFarma Corporation Information
    • 11.5.2 BioFarma Overview
    • 11.5.3 BioFarma Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.5.4 BioFarma Tuberculosis Vaccine Treatment Product Description
    • 11.5.5 BioFarma Related Developments
  • 11.6 GreenSignal Bio Pharma
    • 11.6.1 GreenSignal Bio Pharma Corporation Information
    • 11.6.2 GreenSignal Bio Pharma Overview
    • 11.6.3 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.6.4 GreenSignal Bio Pharma Tuberculosis Vaccine Treatment Product Description
    • 11.6.5 GreenSignal Bio Pharma Related Developments
  • 11.7 China National Biotec
    • 11.7.1 China National Biotec Corporation Information
    • 11.7.2 China National Biotec Overview
    • 11.7.3 China National Biotec Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.7.4 China National Biotec Tuberculosis Vaccine Treatment Product Description
    • 11.7.5 China National Biotec Related Developments
  • 11.8 Biomed Lublin
    • 11.8.1 Biomed Lublin Corporation Information
    • 11.8.2 Biomed Lublin Overview
    • 11.8.3 Biomed Lublin Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.8.4 Biomed Lublin Tuberculosis Vaccine Treatment Product Description
    • 11.8.5 Biomed Lublin Related Developments
  • 11.9 Taj Pharmaceuticals
    • 11.9.1 Taj Pharmaceuticals Corporation Information
    • 11.9.2 Taj Pharmaceuticals Overview
    • 11.9.3 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.9.4 Taj Pharmaceuticals Tuberculosis Vaccine Treatment Product Description
    • 11.9.5 Taj Pharmaceuticals Related Developments
  • 11.10 Ataulpho de Paiva
    • 11.10.1 Ataulpho de Paiva Corporation Information
    • 11.10.2 Ataulpho de Paiva Overview
    • 11.10.3 Ataulpho de Paiva Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.10.4 Ataulpho de Paiva Tuberculosis Vaccine Treatment Product Description
    • 11.10.5 Ataulpho de Paiva Related Developments
  • 11.1 Merck
    • 11.1.1 Merck Corporation Information
    • 11.1.2 Merck Overview
    • 11.1.3 Merck Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.1.4 Merck Tuberculosis Vaccine Treatment Product Description
    • 11.1.5 Merck Related Developments
  • 11.12 Queen Saovabha Mem. Inst
    • 11.12.1 Queen Saovabha Mem. Inst Corporation Information
    • 11.12.2 Queen Saovabha Mem. Inst Overview
    • 11.12.3 Queen Saovabha Mem. Inst Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.12.4 Queen Saovabha Mem. Inst Product Description
    • 11.12.5 Queen Saovabha Mem. Inst Related Developments
  • 11.13 Microgen
    • 11.13.1 Microgen Corporation Information
    • 11.13.2 Microgen Overview
    • 11.13.3 Microgen Tuberculosis Vaccine Treatment Sales, Price, Revenue and Gross Margin (2016-2021)
    • 11.13.4 Microgen Product Description
    • 11.13.5 Microgen Related Developments

12 Value Chain and Sales Channels Analysis

  • 12.1 Tuberculosis Vaccine Treatment Value Chain Analysis
  • 12.2 Tuberculosis Vaccine Treatment Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Tuberculosis Vaccine Treatment Production Mode & Process
  • 12.4 Tuberculosis Vaccine Treatment Sales and Marketing
    • 12.4.1 Tuberculosis Vaccine Treatment Sales Channels
    • 12.4.2 Tuberculosis Vaccine Treatment Distributors
  • 12.5 Tuberculosis Vaccine Treatment Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Tuberculosis Vaccine Treatment Industry Trends
  • 13.2 Tuberculosis Vaccine Treatment Market Drivers
  • 13.3 Tuberculosis Vaccine Treatment Market Challenges
  • 13.4 Tuberculosis Vaccine Treatment Market Restraints

14 Key Findings in The Global Tuberculosis Vaccine Treatment Study

    15 Appendix

    • 15.1 Research Methodology
      • 15.1.1 Methodology/Research Approach
      • 15.1.2 Data Source
    • 15.2 Author Details

    Tuberculosis Vaccine Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Tuberculosis Vaccine Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2016-2027.

    Segment by Type
    Immune Vaccine
    Therapy Vaccine

    Segment by Application
    Self-Procurement
    UNICEF
    Other

    By Company
    Merck
    Japan BCG Lab
    Serum Institute of India
    AJ Vaccines
    BioFarma
    GreenSignal Bio Pharma
    China National Biotec
    Biomed Lublin
    Taj Pharmaceuticals
    Ataulpho de Paiva
    IVAC
    Queen Saovabha Mem. Inst
    Microgen

    By Region
    North America
    U.S.
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    Taiwan
    Indonesia
    Thailand
    Malaysia
    Philippines
    Vietnam
    Latin America
    Mexico
    Brazil
    Argentina
    Middle East & Africa
    Turkey
    Saudi Arabia

    Buy now